Skip to main content
OptumRx × Residential and level-of-care

How to appeal a OptumRx residential and level-of-care denial

Behavioral health and substance-use disorder denials often turn on level-of-care decisions — residential vs. This guide is specific to OptumRx appeals.

Why OptumRx denies residential and level-of-care

OptumRx is UnitedHealth Group's pharmacy benefit manager and administers drug coverage for UHC commercial and Medicare Part D plans, plus many third-party employer groups. The appeal track mirrors UHC procedurally but is filed and decided separately from the medical benefit.

For residential and level-of-care specifically: Behavioral health and substance-use disorder denials often turn on level-of-care decisions — residential vs. partial hospitalization vs. intensive outpatient. Carriers frequently deny residential placement using internal criteria that have been ruled inadequate in landmark litigation, including Wit v. United Behavioral Health.

The OptumRx appeal process

Appeal levels: Coverage determination / exception request, then plan-level redetermination, then external review (IRO commercial; IRE / MAXIMUS for Part D).

Timing: Standard exception: 72 hours. Expedited: 24 hours. Redetermination filing window: 60 days for Part D, 180 days for commercial.

What we know about OptumRx: Where the medical and pharmacy benefits both touch the same therapy (e.g. provider-administered biologics), we file parallel appeals in both lanes to avoid a procedural gap.

Common OptumRx denial patterns for residential and level-of-care

  • Separate appeal track from UHC medical. An OptumRx denial is not a UHC medical denial — and vice versa. Filing the wrong appeal track is one of the most common preventable errors. We confirm whether the denial originated at the pharmacy benefit or the medical benefit before filing.
  • Specialty drug routing through BriovaRx / Optum Specialty. Specialty injectables and infused biologics often route through Optum's specialty pharmacy. Denials at this layer require formulary-exception documentation with clinical rationale, prior-trial data, and (where applicable) FDA-label citation.
  • Part D coverage determinations. OptumRx-administered Part D plans follow the federal 5-level Part D appeal ladder. The IRE for Part D escalation is MAXIMUS Federal Services. Tiering and formulary exceptions are filed before a coverage-determination challenge.

The reversal pathway for residential and level-of-care appeals

Successful residential and level-of-care appeals against OptumRx typically require:

  1. Procedural-rights anchor. Every OptumRx denial triggers ERISA § 503 or 45 C.F.R. § 147.136 procedural rights. The cover letter must invoke these in the opening paragraph to lock the timeline and force criteria disclosure.
  2. Criteria-disclosure demand. OptumRx (like all major insurers) frequently denies on "not medically necessary" without disclosing the clinical criteria applied. Federal law requires they disclose on request — and once they do, the criteria become the rebuttal map.
  3. Treating-provider attestation. A letter from the treating physician explaining medical necessity in the specific terms the carrier's policy uses. This is the single strongest evidentiary element.
  4. Peer-reviewed citations. At least two journal citations (NEJM, JAMA, Lancet, etc.) or specialty-society guidelines (NCCN, AASM, ACR Appropriateness Criteria) supporting the requested service for the patient's clinical profile.
  5. Plan-language anchor. The specific policy section that controls the determination, quoted verbatim with policy section number.
  6. Requested action. Clear, specific request for reversal — not a general "please reconsider."

What Apellica does for OptumRx residential and level-of-care appeals

We file appeals against OptumRx specifically configured to its internal review process. Every appeal includes the criteria-disclosure demand, the procedural-rights anchor, treating-provider attestation language, and the specific peer-reviewed citations relevant to the denied service.

Cost: $0 upfront. We work on contingency for OptumRx appeals — if the appeal succeeds, we collect a percentage of the recovered claim value. If it fails, you owe nothing.

Start your OptumRx residential and level-of-care appeal

Submit a 2-minute intake. A senior reviewer responds within one business day with the specific appeal strategy for your case.

Start free appeal review →

Related OptumRx guides

Other carriers — residential and level-of-care denials guides

Start Free Case Review